LQZ-7I
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-136538-10 mg |
| CAS # | 195822-23-2 |
| Pricing | 10 mg, USD $150.0 |
| Biological Activity | LQZ-7I is a survivin-targeting inhibitor. LQZ-7I inhibits survivin dimerization. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors[1]. |
| Purity | 99.81% |
| MWt | 348.35 |
| Formula | C₂₀H₁₄F₂N₄ |